Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Knight Therapeutics Inc. (T.GUD) had Weighted-Average Shares Outstanding (Diluted) of 101.44M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
3.16M |
|
-- |
|
-- |
|
-- |
|
5.40M |
|
-- |
|
1.50M |
|
1.50M |
|
3.16M |
|
3.16M |
|
3.16M |
|
3.16M |
|
5.40M |
|
44.15M |
|
101.04M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
101.44M |
0.03 |
|
0.03 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
703.21M |
|
-- |
|
-- |
|
-- |
|
123.08M |
|
580.13M |
|
310.10M |
|
580.13M |
|
100.05M |
|
| Cash Flow Statement Financials | |
26.47M |
|
12.38M |
|
-24.47M |
|
42.87M |
|
58.45M |
|
15.57M |
|
1.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.57 |
|
-- |
|
-- |
|
0.04 |
|
0.06 |
|
46.97% |
|
1.99% |
|
1.99% |
|
16.30% |
|
0.55% |
|
1.17% |
|
24.74M |
|
-- |
|
-- |
|
-- |
|
0.39 |
|
1.92 |
|
3.27 |
|
111.61 |
|
0.54% |
|
1.02% |
|
0.45% |
|
0.53% |
|
7.95 |
|
0.24 |
|
0.26 |
|